Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Biomarker phenotype RGD Hematological and morphological investigation of thrombogenic mechanisms in the lungs of phenylhydrazine-treated rats. 22402172 2013
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Therapeutic phenotype RGD Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo. 17293494 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Biomarker phenotype CTD_human Cerebral venous sinus thrombosis as a recurrent thrombotic event in a patient with heterozygous prothrombin G20210A genotype after discontinuation of oral anticoagulation therapy: how long should we treat these patients with warfarin? 17245631 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 GeneticVariation phenotype LHGDN A 10-year-old boy with basilar artery thrombosis who was heterozygous for prothrombin G20210A mutation is described. 17621506 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 GeneticVariation phenotype LHGDN factor V (FV) prevalence is quite high and coexistence of FV Leiden with other hereditary causes of thrombosis such as prothrombin G20210A mutation 17456626 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Biomarker phenotype LHGDN prothrombin 20210 defect should be considered in the differential diagnosis of patients with unexplained thrombosis. 17342369 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Biomarker phenotype LHGDN a significant relationship was determined among FV Leiden, FII G20210A, and thrombosis 17911197 2007
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 GeneticVariation phenotype LHGDN Prothrombin G20210A gene variant does not appear to contribute to the development of portal vein thrombosis in India 16283309 2006
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 GeneticVariation phenotype LHGDN The G20210A prothrombin gene mutation has been identified as predisposing genetic factor for thrombosis. 15958894 2005
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 GeneticVariation phenotype LHGDN the frequency of two thrombin variants, G20210A and C20209T, have been searched in different groups; arterial thrombosis in children was associated with the PT G20210A mutation, but not with the PT C20209T variant 16020118 2005
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 GeneticVariation phenotype LHGDN Prothrombin G20210A polymorphism is a risk factor for the possibility of hepatic artery thrombosis after liver transplantation 12865818 2003
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Biomarker phenotype CTD_human Deep vein thrombosis during enoxaparin prophylactic treatment in a young pregnant woman homozygous for factor V Leiden and heterozygous for the G127-->a mutation in the thrombomodulin gene. 11132655 2001
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Biomarker phenotype CTD_human Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban. 10064001 1999
Entrez Id: 2147
Gene Symbol: F2
F2
0.580 Biomarker phenotype CTD_human Effect of sodium pentosan polysulphate on the thrombogenicity of prothrombin complex concentrates. 1279834 1992
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1
0.510 Therapeutic phenotype RGD Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo. 17293494 2007
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1
0.510 Biomarker phenotype LHGDN Renal hypertension was caused by renal artery obstruction due to thrombus formation/thrombus formation was attributed to antithrombin deficiency caused by a novel SERPINCI gene mutation (AT III Akita, M352R). 15338392 2005
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1
0.510 Biomarker phenotype CTD_human Deep vein thrombosis during enoxaparin prophylactic treatment in a young pregnant woman homozygous for factor V Leiden and heterozygous for the G127-->a mutation in the thrombomodulin gene. 11132655 2001
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1
0.510 Therapeutic phenotype CTD_human Deep vein thrombosis during enoxaparin prophylactic treatment in a young pregnant woman homozygous for factor V Leiden and heterozygous for the G127-->a mutation in the thrombomodulin gene. 11132655 2001
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1
0.510 Biomarker phenotype CTD_human [Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test]. 8967151 1996
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1
0.510 Therapeutic phenotype CTD_human [Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test]. 8967151 1996
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1
0.510 Therapeutic phenotype CTD_human Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome. 2133253 1992
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1
0.510 Biomarker phenotype CTD_human Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome. 2133253 1992
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1
0.510 Therapeutic phenotype CTD_human Estrogen treatment of tall girls: risk of thrombosis? 6889048 1983
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1
0.510 Biomarker phenotype CTD_human Estrogen treatment of tall girls: risk of thrombosis? 6889048 1983
Entrez Id: 64805
Gene Symbol: P2RY12
P2RY12
0.500 Biomarker phenotype RGD Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis. 19692114 2010